Recent News

• 04.11.2025 - 4DMT Announces New Employment Inducement Grants
• 04.03.2025 - RBC Capital Markets 2025 Ophthalmology Conference
• 03.27.2025 - 4DMT to Participate in Upcoming Investor Conferences
• 03.12.2025 - Barclays Global Healthcare Conference
• 03.11.2025 - Leerink's Global Biopharma Conference 2025
• 03.10.2025 - 4DMT Announces First Patients Enrolled in 4FRONT-1 Phase 3 Clinical Trial Evaluating 4D-150 in Wet AMD
• 02.28.2025 - 4DMT Reports Full Year 2024 Financial Results, Operational Highlights and Expected Upcoming Milestones
• 02.19.2025 - 4DMT to Participate in Upcoming Investor Conferences

Recent Filings

• 03.24.2025 - EFFECT Notice of Effectiveness
• 03.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.28.2025 - 8-K Current report
• 02.28.2025 - POS AM Post-Effective amendments for registration statement
• 02.28.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.28.2025 - POSASR Post-effective Amendment to an automatic shelf registration statement